Bill Text: TX HB4332 | 2023-2024 | 88th Legislature | Enrolled
Bill Title: Relating to the redistribution of donated prepackaged prescription drugs.
Spectrum: Partisan Bill (Republican 3-0)
Status: (Passed) 2023-06-12 - Effective on 9/1/23 [HB4332 Detail]
Download: Texas-2023-HB4332-Enrolled.html
| H.B. No. 4332 | ||
|
|
||
| relating to the redistribution of donated prepackaged prescription | ||
| drugs. | ||
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
| SECTION 1. Section 442.001, Health and Safety Code, is | ||
| amended by adding Subdivision (6-a) to read as follows: | ||
| (6-a) "Prepackage" means the act of repackaging and | ||
| relabeling varying quantities of prescription drugs from a | ||
| manufacturer's original commercial container into a prescription | ||
| container, unit-dose packaging, or a multi-compartment container | ||
| for a pharmacist to dispense to a consumer. | ||
| SECTION 2. Subchapter B, Chapter 442, Health and Safety | ||
| Code, is amended by adding Section 442.0515 to read as follows: | ||
| Sec. 442.0515. REDISTRIBUTION OF DONATED PREPACKAGED | ||
| PRESCRIPTION DRUGS. (a) A participating provider may dispense to a | ||
| recipient donated prescription drugs that are prepackaged and | ||
| labeled in accordance with this section and rules adopted by the | ||
| Texas State Board of Pharmacy. | ||
| (b) A prepackaged prescription drug a participating | ||
| provider dispenses to a recipient must contain a label that | ||
| includes: | ||
| (1) the drug's brand name or, for a generic version of | ||
| the drug, the drug's generic name and the manufacturer or | ||
| distributor of the drug; | ||
| (2) the amount of the drug in a given dose; | ||
| (3) the drug's lot number; | ||
| (4) the earliest expiration date of the drug for that | ||
| drug lot number; and | ||
| (5) the quantity of any drug the provider dispenses in | ||
| more than one dose. | ||
| (c) A participating provider shall maintain a record of each | ||
| prepackaged prescription drug dispensed to a recipient. The record | ||
| must include: | ||
| (1) the drug's name, the amount of the drug in a given | ||
| dose, and the dosage size or frequency; | ||
| (2) the provider's lot number for that drug; | ||
| (3) the drug's manufacturer or distributor; | ||
| (4) the manufacturer's lot number for that drug; | ||
| (5) the expiration dates of the drug from that drug's | ||
| lot number; | ||
| (6) the quantity of the drug in each prepackaged unit; | ||
| (7) the number of prepackaged units that include the | ||
| drug; | ||
| (8) the date the drug was prepackaged; | ||
| (9) the name, initials, or written or electronic | ||
| signature of the individual who prepackaged the drug; and | ||
| (10) the written or electronic signature of the | ||
| pharmacist responsible for the drug's prepackaging. | ||
| SECTION 3. As soon as practicable after the effective date | ||
| of this Act, the Texas State Board of Pharmacy shall adopt any rules | ||
| necessary to implement the changes in law made by this Act. | ||
| SECTION 4. This Act takes effect September 1, 2023. | ||
| ______________________________ | ______________________________ | |
| President of the Senate | Speaker of the House | |
| I certify that H.B. No. 4332 was passed by the House on April | ||
| 28, 2023, by the following vote: Yeas 140, Nays 4, 2 present, not | ||
| voting. | ||
| ______________________________ | ||
| Chief Clerk of the House | ||
| I certify that H.B. No. 4332 was passed by the Senate on May | ||
| 17, 2023, by the following vote: Yeas 31, Nays 0. | ||
| ______________________________ | ||
| Secretary of the Senate | ||
| APPROVED: _____________________ | ||
| Date | ||
| _____________________ | ||
| Governor | ||
